• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Health

Could over-the-counter pain relievers be making your back pain worse?

By
Kendall K. Morgan
Kendall K. Morgan
Down Arrow Button Icon
By
Kendall K. Morgan
Kendall K. Morgan
Down Arrow Button Icon
May 31, 2022, 6:30 PM ET
woman with back pain
Using anti-inflammatory medicines may make back pain worse.Sciene Photo Library—Getty Images

Low back pain is the most common and debilitating of all pain complaints. Heavy lifting can cause it, but so can sitting at a desk all day, especially if you have bad posture and poor back support. Think hunching over a laptop at your dining table. Most times, an acute injury causing lower back pain will get better on its own in a matter of weeks. But it also can become a more lasting problem, especially as you age. Now some new science suggests one reason for this could be that we’ve been approaching the inflammation that comes with back pain all wrong.

“Most back pain is caused by a run-of-the-mill sprain,” says Frederick Wilson, DO, a doctor of osteopathic medicine specializing in back pain at Cleveland Clinic’s Solon Family Health Center in Solon, OH, who was not involved with the study. “You might be working in the yard or playing football with the kids and you wrench it.”

Wilson says such injuries often involve muscle spasms and micro-tears in your ligaments. Current recommendations would have you reaching for ibuprofen or another anti-inflammatory medicine to help relieve the pain and swelling. But a recent study in Science Translational Medicine suggests that inflammation in the early days of back pain isn’t the problem. It actually may be a critical step for the body to heal itself and resolve the pain. It’s when that active healing process doesn’t happen, the new study finds, that an acute back injury leads to chronic problems.

“It’s interesting and completely different from how we’ve approached it before,” Wilson said of the findings.

When Acute Pain Turns Chronic

The new study suggests that using anti-inflammatory medicines to treat a back injury might be a short-term fix with risks for creating longer-term problems. It came as an unexpected surprise to the scientists who discovered it, including Luda Diatchenko, MD, PhD, a pain researcher at McGill University in Montreal, Quebec. She and her colleagues wanted to pinpoint what happens in the body when acute low back pain becomes chronic.

To do it, they looked carefully at immune cells in the bloodstream of 98 people with acute low back pain. They were in search of differences between those whose back pain went away within three months and those whose pain persisted. It turned out that the difference was striking and the opposite of what they’d anticipated. Those who got better showed signs of a dynamic process, including thousands of underlying molecular-level changes consistent with an inflammatory response.

“In people who resolved pain, we saw these huge biological processes,” Diatchenko says. In people who didn’t? “Absolutely nothing happened. It was just like complete silence. So the development of disease isn’t an active process. It’s the absence of this adaptive [inflammatory] process.”

A New Way to Treat Pain?

The differences they saw weren’t explained by any medicine people in the study were taking or not taking. But they do suggest that treating acute back pain in ways that limit the body’s natural inflammatory responses might be counterproductive. To investigate further, the researchers tested the idea in mice. Those studies found that blocking certain immune cells made the animals’ pain last 10 times longer. Treating them with anti-inflammatory medicines had a similar effect. They got more support for the idea from an analysis of data from about 500,000 people with acute back pain in the United Kingdom. It showed that those who treated their pain with NSAIDS, anti-inflammatory medicines including aspirin, ibuprofen, and naproxen (Aleve), more often still had pain years later.

Based on the findings, the researchers say that it may be time to reconsider how acute pain is treated. They are calling for a clinical trial to look at the long-term effects of NSAIDs for acute pain. These medicines can help an injury feel better temporarily but, Diatchenko notes, they don’t have much effect once back pain becomes chronic. Still she doesn’t think the focus should be only on NSAIDs. It’s important also to find ways to boost the body’s natural healing processes.

“People often concentrate on [NSAIDs] and underestimate the other part,” says Diatchenko. “We shouldn’t inhibit our responses. We should enhance them and help our body heal itself.”

Promote Natural Healing

Diatchenko says the findings might explain why physical therapy, exercise, and acupuncture often work better than medicine for relieving back pain since they stimulate activity in the body rather than dampen it. As an osteopath, Wilson notes that he also treats his patients with spinal manipulations that bring blood flow to the area and the new findings may offer clues to how this helps.

The best way to avoid chronic low back pain is to avoid injury in the first place. Wilson suggests warming up to get your muscles loose before engaging in weekend activities such as working in the garden. Use correct body mechanics, such as lifting with your legs not your back. Instead of squatting and twisting, try sitting on a stool. When you work from home, make sure your computer screen, keyboard, and chair are arranged so you’re not constantly looking up or down and can use the keyboard without your shoulders slumping. Sit in a chair that gives your lower back support, and sleep on a mattress for back pain. If you do have back pain, Wilson says, use anti-inflammatory medicines only when you really need to—not around the clock—given their other risks, such as stomach problems and kidney damage. Focus instead on icing the injury to keep any swelling and pain you’ve got manageable while staying as active as you can.

“Don’t lay down for two days or you put yourself at risk of getting weaker,” he says. “You want to try to keep moving if you can. Just don’t push it and listen to your body.”

Sign up for the Fortune Features email list so you don’t miss our biggest features, exclusive interviews, and investigations.
About the Author
By Kendall K. Morgan
See full bioRight Arrow Button Icon

Latest in Health

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025

Most Popular

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
Fortune Secondary Logo
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

Latest in Health

Big TechSocial Media
YouTube’s cofounder and former tech boss doesn’t want his kids to watch short videos, warning short-form content ‘equates to shorter attention spans’
By Marco Quiroz-GutierrezMarch 1, 2026
2 days ago
HealthTikTok
Gen Z men are eating ‘boy kibble,’ the human equivalent to dog food, to load up on protein cheaply
By Jake AngeloMarch 1, 2026
2 days ago
Healthsleep
8 Best Firm Mattresses in 2026: Tested and Reviewed by Sleep Experts
By Christina SnyderFebruary 27, 2026
4 days ago
HealthFood and drink
Chains like Sweetgreen and Chipotle are finally realizing they need to look beyond the ‘slop bowl’
By Phil WahbaFebruary 27, 2026
4 days ago
chat
Healthchat
Here are the 7 rules of group chats, including how to leave when you’ve had enough
By Kelvin Chan and The Associated PressFebruary 27, 2026
4 days ago
will
CommentaryAdvertising
I’m one of America’s top pollsters and I’ve got a warning for the AI companies: customers aren’t sold on ads
By Will JohnsonFebruary 27, 2026
4 days ago

Most Popular

placeholder alt text
Middle East
U.S. military gives Iran a taste of its own medicine with cheap copycat Shahed drones, while concern shifts to munitions supply in extended conflict
By Jason MaMarch 1, 2026
2 days ago
placeholder alt text
Success
Slack cofounder says workers and CEOs can get stuck doing 'fake' work like pre-meetings and slideshows
By Emma BurleighMarch 1, 2026
2 days ago
placeholder alt text
Success
MacKenzie Scott's close relationship with Toni Morrison long before Amazon put Scott on the path to give more than $1 billion to HBCUs
By Sasha RogelbergMarch 1, 2026
2 days ago
placeholder alt text
Economy
Your grandparents are the reason the U.S. isn't in a recession right now. That won't last forever
By Eleanor PringleMarch 1, 2026
2 days ago
placeholder alt text
AI
American schools weren’t broken until Silicon Valley used a lie to convince them they were—now reading and math scores are plummeting
By Sasha RogelbergMarch 1, 2026
2 days ago
placeholder alt text
Personal Finance
Current price of silver as of Monday, March 2, 2026
By Joseph HostetlerMarch 2, 2026
23 hours ago

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.